Inventor · disambiguated record
Cornelis Arjan Van Oeveren
Also filed as: VAN OEVEREN CORNELIS A · VAN OEVEREN CORNELIS ARJAN
22 granted patents·4 pending applications·253 citations·filing 2000–2021
95Inventor score
Top patents by PatentIndex Score
26 records- 0194US7696246B2Bicyclic androgen and progesterone receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2005·Granted Apr 13, 2010·22 cites·32 claims
- 0293US7727980B2Tricyclic androgen receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2006·Granted Jun 1, 2010·22 cites·64 claims
- 0393US6566372B1Bicyclic androgen and progesterone receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2000·Granted May 20, 2003·103 cites·24 claims
- 0491US8865918B2Androgen receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2013·Granted Oct 21, 2014·15 cites·17 claims
- 0588US7071205B25-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compoundsLIGAND PHARM INC·Filed 2003·Granted Jul 4, 2006·26 cites·29 claims
- 0687US10030034B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2016·Granted Jul 24, 2018·5 cites·12 claims
- 0786US7084151B25-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compoundsLIGAND PHARM INC·Filed 2003·Granted Aug 1, 2006·22 cites·11 claims
- 0885US9266874B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2013·Granted Feb 23, 2016·2 cites·9 claims
- 0985US7026484B2Tricyclic androgen receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2002·Granted Apr 11, 2006·21 cites·61 claims
- 1084US10604533B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2018·Granted Mar 31, 2020·1 cites·15 claims
- 1183US11186593B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2020·Granted Nov 30, 2021·1 cites·19 claims
- 1283US8519158B2Androgen receptor modulator compounds and methodsZHI LIN·Filed 2005·Granted Aug 27, 2013·7 cites·44 claims
- 1376US11773110B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2021·Granted Oct 3, 2023·0 cites·11 claims
- 1473US9144557B2Hematopoietic growth factor mimetic small molecule compounds and their usesZHI LIN·Filed 2010·Granted Sep 29, 2015·3 cites·21 claims
- 1572US9359285B2Androgen receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2014·Granted Jun 7, 2016·1 cites·13 claims
- 1670US11413274B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 1767US9622991B2Hematopoietic growth factor mimetic small molecule compounds and their usesLIGAND PHARM INC·Filed 2015·Granted Apr 18, 2017·1 cites·23 claims
- 1866US10736875B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2018·Granted Aug 11, 2020·0 cites·16 claims
- 1964US8580811B2Androgen receptor modulator methodsPEDRAM BIJAN·Filed 2012·Granted Nov 12, 2013·1 cites·14 claims
- 2051US2006223839A15-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno-[3,4-f]-quinolines as selective progesterone receptor modulator compoundsZHI LIN·Filed 2006·Application pending·0 cites
- 2150US8193357B2Androgen receptor modulator compoundsPEDRAM BIJAN·Filed 2006·Granted Jun 5, 2012·0 cites·16 claims
- 2250US2006194827A15-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compoundsZHI LIN·Filed 2006·Application pending·0 cites
- 2346US7163946B25-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compoundsLIGAND PHARM INC·Filed 2003·Granted Jan 16, 2007·0 cites·25 claims
- 2446US2010210678A1Tricyclic androgen receptor modulator compounds and methodsZHI LIN·Filed 2010·Application pending·0 cites
- 2545US2009203725A1Androgen Receptor Modulator Compounds and MethodsVAN OEVEREN CORNELIS ARJAN·Filed 2006·Application pending·0 cites
- 2629US8680150B2Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptorsZHI LIN·Filed 2010·Granted Mar 25, 2014·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Cornelis Arjan Van Oeveren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →